These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 1973178)

  • 21. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
    Trainer PJ; Faria M; Newell-Price J; Browne P; Kopelman P; Coy DH; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1995 Feb; 80(2):412-7. PubMed ID: 7852498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benzodiazepines attenuate the pituitary-adrenal responses to corticotrophin-releasing hormone in healthy volunteers, but not in patients with Cushing's syndrome.
    Korbonits M; Trainer PJ; Edwards R; Besser GM; Grossman AB
    Clin Endocrinol (Oxf); 1995 Jul; 43(1):29-35. PubMed ID: 7641409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing's syndrome.
    Avgerinos PC; Chrousos GP; Nieman LK; Oldfield EH; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1987 Nov; 65(5):906-13. PubMed ID: 3499448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
    Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
    N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide.
    Reznik Y; Allali-Zerah V; Chayvialle JA; Leroyer R; Leymarie P; Travert G; Lebrethon MC; Budi I; Balliere AM; Mahoudeau J
    N Engl J Med; 1992 Oct; 327(14):981-6. PubMed ID: 1325609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen secretion in ectopic ACTH syndrome and in Cushing's disease: modifications before and after surgery.
    Barbetta L; Dall'Asta C; Re T; Colombo P; Travaglini P; Ambrosi B
    Horm Metab Res; 2001 Oct; 33(10):596-601. PubMed ID: 11607879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FK 33-824, a met-enkephalin analog, blocks corticotropin-releasing hormone-induced adrenocorticotropin secretion in normal subjects but not in patients with Cushing's disease.
    Allolio B; Deuss U; Kaulen D; Leonhardt U; Kallabis D; Hamel E; Winkelmann W
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1427-31. PubMed ID: 3023423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baseline and CRH-stimulated ACTH and cortisol levels after administration of the peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone, in Cushing's disease.
    Cannavò S; Ambrosi B; Chiodini I; Vigo T; Russo A; Milici C; Barbetta L; Dall'Asta C; Adda G; Arosio M
    J Endocrinol Invest; 2004 May; 27(5):RC8-11. PubMed ID: 15279069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
    Demitrack MA; Dale JK; Straus SE; Laue L; Listwak SJ; Kruesi MJ; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The activation of somatostatinergic receptors by either somatostatin-14 or cortistatin-17 often inhibits ACTH hypersecretion in patients with Cushing's disease.
    Giordano R; Picu A; Bonelli L; Broglio F; Prodam F; Grottoli S; Muccioli G; Ghigo E; Arvat E
    Eur J Endocrinol; 2007 Oct; 157(4):393-8. PubMed ID: 17893252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
    Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
    Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclic Cushing's syndrome combined with cortisol suppressible, dexamethasone non-suppressible ACTH secretion: a new variant of Cushing's syndrome.
    Schweikert HU; Fehm HL; Fahlbusch R; Martin R; Kolloch R; Higuchi M; Krück F
    Acta Endocrinol (Copenh); 1985 Nov; 110(3):289-95. PubMed ID: 3000118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease.
    Suri D; Weiss RE
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1340-6. PubMed ID: 15585550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of effect of desmopressin on ACTH and cortisol responses to ovine corticotropin-releasing hormone in anorexia nervosa.
    Foppiani L; Sessarego P; Valenti S; Falivene MR; Cuttica CM; Giusti Disem M
    Eur J Clin Invest; 1996 Oct; 26(10):879-83. PubMed ID: 8911861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adrenocorticotropin levels do not change during early recovery of transsphenoidal surgery for ACTH-secreting pituitary tumors.
    Pimentel-Filho FR; Cukiert A; Miyashita F; Huayllas MK; Knoepfelmacher M; Salgado LR; Liberman B
    J Endocrinol Invest; 2001 Feb; 24(2):83-7. PubMed ID: 11263476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute and long-term effects of octreotide in patients with ACTH-dependent Cushing's syndrome.
    Woodhouse NJ; Dagogo-Jack S; Ahmed M; Judzewitsch R
    Am J Med; 1993 Sep; 95(3):305-8. PubMed ID: 8396322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of CRH-induced secretion of ACTH and corticosterone by SOM230 in rats.
    Silva AP; Schoeffter P; Weckbecker G; Bruns C; Schmid HA
    Eur J Endocrinol; 2005 Sep; 153(3):R7-R10. PubMed ID: 16131595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure of somatostatin analogue to control Cushing's syndrome in two cases of ACTH-producing carcinoid tumours.
    Cheung NW; Boyages SC
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):361-7. PubMed ID: 1424169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated plasma 19-hydroxyandrostenedione levels in Cushing's disease: stimulation with ACTH and inhibition with metyrapone.
    Mune T; Morita H; Yasuda K; Murayama M; Yamakita N; Miura K
    Clin Endocrinol (Oxf); 1993 Mar; 38(3):265-72. PubMed ID: 8384536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.